B-Lineage lymphoid malignancies
Showing 1 - 25 of >10,000
Leukemia, Lymphoma Trial in Houston (HSCT, DLI)
Completed
- Leukemia
- Lymphoma
- HSCT
- DLI
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 9, 2021
Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)
Completed
- Lymphoma
- B-cell Lymphoma
- Leukapheresis
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)
Not yet recruiting
- ALL, Childhood B-Cell
- +2 more
- Tafasitamab
- (no location specified)
Nov 25, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Pediatric and Young Adult B-Cell Malignancies After Commercially
Not yet recruiting
- Lymphoid Leukemia
- Questionnaire for patients receiving therapy
-
Palo Alto, CaliforniaStanford University
May 9, 2023
MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)
Recruiting
- Myelodysplastic Syndromes, de Novo
- +10 more
- Venetoclax
- +10 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 23, 2023
B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)
Not yet recruiting
- B-All
- Acute Lymphoblastic Leukemia
- NGS testing
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,
Active, not recruiting
- B-Lymphoid Malignancies
- +3 more
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 1, 2022
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- Cyclophosphamide
- +2 more
-
São Paulo, BrazilHospital Israelita Albert Einstein
Jan 20, 2023
Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase
Recruiting
- Lymphoblastic Leukemia
- +4 more
- Phase I
- Phase II
-
Singapore, SingaporeKK Women's and Children's hospital
Jun 20, 2022
Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T
Recruiting
- Acute Myeloid Leukemia (AML)
- +4 more
- Autologous CAR-T cells
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Pudong Hospital, Fudan University Affiliated Pudong Med
Aug 22, 2022
B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma Trial (Autologous Humanized CD19-Directed Chimeric
Not yet recruiting
- B Cell Acute Lymphoblastic Leukemia (B-ALL)
- B Lineage Lymphoblastic Lymphoma
- Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
- (no location specified)
Jul 27, 2022
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,
Terminated
- Non-Hodgkins Lymphoma
- +6 more
-
Huntsville, Alabama
- +1 more
May 5, 2022
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston
Recruiting
- Mantle Cell Lymphoma
- +9 more
- L-Bcl-2 antisense oligonucleotide
-
Augusta, Georgia
- +2 more
Nov 18, 2022
Blood And Marrow Transplantation, Leukemia, Lymphoma Trial (Cyclophosphamide, Fludarabine, T-Cell Infusion)
Withdrawn
- Blood And Marrow Transplantation
- +2 more
- Cyclophosphamide
- +2 more
- (no location specified)
Jan 17, 2020
B-cell Malignancies Undergoing Treatment With Bruton Tyrosine
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Fairway, Houston (SC291)
Recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
-
Fairway, Kansas
- +1 more
May 30, 2023
Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Anti-CD19 and anti-CD20 bicistronic CAR T- cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- +6 more
- (no location specified)
Apr 12, 2023